Beta-Endorphin: dissociation of receptor binding activity from analgesic potency.

AUTOR(ES)

Li, C H

RESUMO

Biological activities of synthetic camel beta-endorphin and human beta-endorphin (beta h-EP) have been measured by the radioreceptor binding assay, using [Tyr27-3H]-beta h-EP as the primary ligand and by the tail-flick test for analgesic potency. Four synthetic analogs of beta h-EP, namely [Gly31]-beta h-EP-Gly-NH2, [Gly31]-beta h-EP-Gly-Gly-NH2, [Gln8,Gly31]-beta h-EP-Gly-Gly-NH2, and [CH3(CH2)4NH231]-beta h-EP, have also been assayed by the same procedures. Results indicate a clear dissociation of radioreceptor binding activity from analgesic potency.

Documentos Relacionados

• beta-Endorphin: behavioral and analgesic activity in cats.
• Beta-endorphin: replacement of tyrosine in position 27 by tryptophan increases analgesic potency--preparation and properties of the 2-nitrophenylsulfenyl derivative.
• beta-Endorphin: surface binding and internalization in thymoma cells.
• beta-Endorphin: characteristics of binding sites in rabbit spinal cord.
• beta-Endorphin: characteristics of binding sites in a neuroblastoma--glioma hybrid cell.